230 Ces Urol 2022; 26(4): 224–231 PŘEHLEDOVÝ ČLÁNEK 2. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798): 270–273. 3. Salian VS, Wright JA, Vedell PT, et al. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies. Molecular Pharmaceutics. 2021; 18(3): 754–771. 4. Collins AB, Zhao L, Zhu Z, et al. Impact of COVID-19 on Male Fertility. Urology. 2022; 164: 33–39. 5. Gonzalez DC, Khodamoradi K, Pai R, et al. A Systematic Review on the Investigation of SARS‑CoV-2 in Semen. Res Rep Urol. 2020; 12: 615–621. 6. Haque A, Pant AB. Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy. Journal of Autoimmunity. 2022; 127: 102792. 7. Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical sym‑ ptoms in COVID-19 patients: a systematic review and meta‑analysis. J Prev Med Hyg. 2020; 61(3): E304–312. 8. Lin L, Jiang X, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS‑CoV-2 infection. Gut. 2020; 69: 997–1001. 9. Chen X, Laurent S, Oezguer AO, et al. A systematic review of neurological symptoms and complications of COVID-19. Journal of Neurology. 2021; 268: 392–402. 10. Odriozola‑Gonzalez P, Planchuelo‑Gómez Á, Jesús IrurtiaM, de Luis‑García R. Psychological symptoms of the outbreak of the COVID-19 confinement in Spain. Journal of Health Psychology. 2022; 27(4): 825–835. 11. Team CDCC 19 R. SARS‑CoV-2 B.1. 1. 529 (Omicron) Variant - United States, December 1-8, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(50): 1731–1734. 12. Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin‑converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS‑CoV-2 infection. European Journal of Clinical Microbiology & Infectious Diseases. 2021; 40(5): 905–919. 13. Seymen CM. The other side of COVID-19 pandemic: Effects on male fertility. 2020; 93(3): 1396–1402. 14. Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression pro¢ling of ACE 2, a novel homologue of angiotensin converting enzyme. 2002; 532(1-2): 107–110. 15. Li W, MooreMJ, Vasilieva N, et al. Angiotensin‑converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965): 450–454. 16. Sengupta P, Dutta S, Slama P, Roychoudhury S. COVID-19, oxidative stress, and male reproductive dys‑ functions: is vitamin C a potential remedy? Physiol Res. 2022; 71(1): 47–54. 17. Jian S, Yushun W, Chuming L, et al. Cell entry mechanisms of SARS‑CoV-2. Proceedings of the National Academy of Sciences. 2020; 117(21): 11727–11734. 18. Younis JS, Abassi Z, Skorecki K. Is there an impact of the COVID-19 pandemic onmale fertility? The ACE2 connection. American Journal of Physiology‑Endocrinology and Metabolism. 2020; 318(6): E878–880. 19. Douglas GC, O’BryanMK, Hedger MP, et al. The novel Angiotensin‑Converting Enzyme (ACE) homolog, ACE2, is selectively expressed by adult leydig cells of the testis. Endocrinology. 2004; 145(10): 4703–4711. 20. Reis AB, Fabiano CA, Pereira VM, et al. Angiotensin (1–7) and its receptor Mas are expressed in the human testis: implications for male infertility. 2010; 41(1): 75–80 21. Liu X, Chen Y, Tang W, et al. Single‑cell transcriptome analysis of the novel coronavirus (SARS‑CoV-2) associated gene ACE2 expression in normal and non‑obstructive azoospermia (NOA) human male testes. Science China Life Sciences. 2020; 63(7): 1006–1015. 22. Wang K, Chen W, Zhou YS, et al. SARS‑CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv. 2020. 23. Cantuti‑Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS‑CoV-2 cell entry and provides a possible pathway into the central nervous system. BioRxiv. 2020. 24. Yang M, Chen S, Huang B, et al. Pathological Findings in the Testes of COVID-19 Patients: Clinical Impli‑ cations. Eur Urol Focus. 2020; 6(5): 1124–1129.
RkJQdWJsaXNoZXIy NDA4Mjc=